Docking Studies of Phthalimide Pharmacophore as a Sodium Channel Blocker

Authors

1 Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

2 Department of Medicinal Chemistry, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran

Abstract

 

Objective(s): Recently, phthalimide derivatives were designed based on ameltolide and thalidomide as they possess a similar degree of anticonvulsant potency due to their phenytoin-like profile. The ability of phthalimide pharmacophore to interact with neuronal voltage-dependent sodium channels was studied in the batrachotoxin affinity assay. Therefore, in the present study, a series of 19 compounds of phthalimide pharmacophore possessing a variety of substituents (NO2, NH2
, Me, Cl, COOH, MeO) at 2-, 3-, and 4- position of the N-phenyl ring and N-(3-amino-2-methylphenyl) succinimide, were subjected to docking studies in order to inhibit voltage-gated sodium channels.
 
Materials and Methods
: Chemical structures of all compounds were designed using HYPERCHEM program and Conformational studies were performed through semi-empirical molecular orbital calculations method followed by PM3 force field. Total energy gradient calculated as a root mean square (RMS) value, until the RMS gradient was 0.01 kcal mol-1. Among all energy minima conformers, the global minimum of compounds was used in docking calculations. Using a model of the open pore of Na channels, docking study was performed by AUTODOCK4.2 program.
Results
: Docking studies have revealed that these types of ligands interacted mainly with II-S6 residues of NaV1.2 through making hydrogen bonds and have additional hydrophobic interactions with domain I, II, III and IV in the channel's inner pore.
Conclusion
 
: These computational studies have displayed that these compounds are capable of inhibiting Na channel, efficiently.

Keywords


 

1. Stefan H, Feuerstein T. Novel anticonvulsant drugs. Pharmacol Ther 2007; 113:165.

2. Donner EJ, Snead OC. New generation anticonvulsants for the treatment of epilepsy in children. Neuro Rx 2006; 3:170.

3. Brodie MJ. Antiepileptic drug therapy the story so far. Seizure 2010; 19:650-55.

4. Lacoste L, Bartolucci S, Lapointey J. Pentylenetetrazole inhibits glutamate dehydrogenase and aspartate aminotransferase, and stimulates GABA aminotransferase in homogenates from rat cerebral cortex. J Physiol Pharmacol 1988; 66:1135-1138.

5. Yuesheng W, Jones PJ, Batts TW, Landry V, Patel MK,Brown ML. Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin–lidocainepharmacophore. Bioorg Med Chem 2009; 17:7064-7072.

6. Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol 2001; 63:871.

7. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005; 57:397–409.

8. Vamecq J, Bac P, Herrenknecht CHJ, Maurois P, Delcourt P, Stables JP. Synthesis and anticonvulsant and neurotoxic properties of substituted N-phenyl derivatives of the phthalimide pharmacophore. J Med Chem 2000; 43:1311-1319.

9. Małgorzata W, Katarzyna KK. Synthesis and anticonvulsant evaluation of some N-substituted phthalimides. Acta Pol Pharm Drug Res 2009; 66: 249-257.

10. Davood A, Iman M. Docking and QSAR studies of b-phenylethylidenehydrazine

derivatives as a Gamma-aminobutyric acid aminotransferase inhibitor. Med Chem Res 2011; 20:955-961.

11. Lipkind GM, Fozzard HA. Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels. Mol Pharmacol 2005; 68:1611-1622.

12. Morris GM, Goodsell, DS, Pique ME, Lindstrom WL, Huey R, Forli S, et al. AutoDock4 and autoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009; 30: 2785-2291.

13. Cosconati S, Marinelli L, Lavecchia A, Novellino E. Characterizing The 1,4-dihydropyridines binding interactions in the L-type Ca

2+ channel: model construction and docking calculations. J Med Chem 2007; 50:1504-1113.

14. Storici P, De Biase D, Bossa F, Bruno S, Mozzarelli A, Peneff C, et al. Structures of {gamma}-aminobutyric acid (GABA) aminotransferase, a pyridoxal50-phosphate, and [2Fe-2S] cluster-containing enzyme, complexedwith {gamma}-ethynyl-GABA and with the antiepilepsydrug vigabatrin. J Biol Chem 2004; 279:363.

15. Davood A, Nematollahi A, Iman M, Shafiee A. Synthesis and docking studies of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent as novel calcium channel agonist. Arch Pharm Res 2009; 32:481-487.

16. O'Reilly AO, Khambay BPS, Williamson MS, Field LM, WAllace BA, Emyr Davies TG. Modelling insecticide-binding sites in the voltage-gated sodium channel. Biochem J 2006; 396:255-263.

17. Huey R, Morris GM. Using Autodock 4 with Autodocktools: A Tutorial. The Scripps Research Institute, USA. 2008; 54-56.